PLAVIX

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug PLAVIX contains one active pharmaceutical ingredient (API):

1	Clopidogrel UNII 08I79HTP27 - CLOPIDOGREL BISULFATE
	Clopidogrel is a prodrug, one of whose metabolites is an inhibitor of platelet aggregation. Clopidogrel must be metabolised by CYP450 enzymes to produce the active metabolite that inhibits platelet aggregation.
	Read more about Clopidogrel

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PLAVIX 75mg Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
PLAVIX Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AC04	Clopidogrel	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	576720030058817
CA	Health Products and Food Branch	02238682
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00051055, 00262119, 00276995, 00549105, 00956187, 01037040, 01146906, 01236905, 01423292, 01501997, 01737530, 01813774, 02418910, 04129423, 04408100, 04412544, 04551033, 06326292, 07770764, 07770770, 09629082, 10227897, 10947189, 16529518, 16817660
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	22.734-1-09-06
EE	Ravimiamet	1040588, 1065732, 1065743, 1131118, 1304941, 1304952, 1304963, 1364622, 1364633, 1364644, 1471395, 1471407
ES	Centro de información online de medicamentos de la AEMPS	98069001, 98069001AIP, 98069001AIP3, 98069002, 98069009
FI	Lääkealan turvallisuus- ja kehittämiskeskus	020847, 124119, 511832
FR	Base de données publique des médicaments	60562855, 63564053
GB	Medicines & Healthcare Products Regulatory Agency	121843, 136636, 139459, 147215, 375286, 375289, 376935, 381632
HK	Department of Health Drug Office	43787, 57453
IE	Health Products Regulatory Authority	40901, 41021, 41080, 41086, 41095
IL	מִשְׂרַד הַבְּרִיאוּת	3779
IT	Agenzia del Farmaco	034128013, 043220019, 043976012, 044418010, 044667018, 044811014, 049461015
JP	医薬品医療機器総合機構	3399008F1025, 3399008F2021
LT	Valstybinė vaistų kontrolės tarnyba	1003137, 1005409, 1008163, 1008164, 1030244, 1030245, 1030246, 1030248, 1030249, 1030250, 1030251, 1030252, 1030253, 1030254, 1032122, 1032123, 1032124, 1056121, 1056122, 1064250
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	474M98
NL	Z-Index G-Standaard, PRK	124559, 124567
PL	Rejestru Produktów Leczniczych	100084778, 100192769
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69341001, W69341006, W69341007, W69341008, W69341009, W69341010, W69341011, W69341012, W69341013, W69341014, W69341015, W69341016, W69341017, W69341018, W69341019, W69341020
SG	Health Sciences Authority	09828P, 14332P
TN	Direction de la Pharmacie et du Médicament	3723023H, 9263241
TR	İlaç ve Tıbbi Cihaz Kurumu	8699809097698, 8699809098190
US	FDA, National Drug Code	0024-1171, 0024-1332, 55289-911, 63653-1171, 63653-1332
ZA	Health Products Regulatory Authority	36/8.2/0408